Arsenic: An Effective New Treatment for Acute Promyelocytic Leukemia
Arsenic: An Effective New Treatment for Acute Promyelocytic Leukemia Acute promyelocytic leukemia is a cancer of the blood. Initial treatment typically consists of all-trans retinoic acid (ATRA) and...
View ArticleFDA Approves Arsenic for Treatment of Promyelocytic Leukemia
FDA Approves Arsenic for Treatment of Promyelocytic Leukemia The Food and Drug Administration has recently approved a chemotherapy agent, arsenic, for patients with acute promyelocytic leukemia who...
View ArticlePatients Die Unexpectedly Following Treatment with Arsenic Trioxide
Patients Die Unexpectedly Following Treatment with Arsenic Trioxide Three sudden deaths occurred in a small clinical trial involving patients treated with arsenic trioxide for recurrent acute...
View ArticleIntensified Induction Therapy May Reduce Relapses in APL
Intensified Induction Therapy May Reduce Relapses in APL According to results recently presented at the 43 rd annual meeting of the American Society of Hematology, evidence suggests that patients with...
View ArticleATRA Plus Trisenox®: A Promising Treatment for Acute Promyelocytic Leukemia
ATRA Plus Trisenox®: A Promising Treatment for Acute Promyelocytic Leukemia According to results presented at the 2003 annual meeting of the American Society of Hematology, the combination of all...
View ArticleElderly with Acute Promyelocytic Leukemia Achieve Long-Term Survival with...
Elderly with Acute Promyelocytic Leukemia Achieve Long-Term Survival with Treatment According to results published in a recent advanced online article in the journal Blood, long-term cancer-free...
View ArticleArsenic Trioxide Effective as Single Agent in Newly Diagnosed APL
Arsenic Trioxide Effective as Single Agent in Newly Diagnosed APL According to an article recently published in the journal Blood, the agent arsenic trioxide, when used as a single agent, provides...
View ArticleSeptember Is National Leukemia and Lymphoma Awareness Month
As the month of September brings leukemia and lymphoma into focus, it’s time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention,...
View ArticleMany Patients with “Chemo Brain” Recover within Five Years
A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients....
View ArticleCaring for Yourself During Chemotherapy for Leukemia: How to Manage Hair...
Chemotherapy can be effective treatment for cancer but may also cause physical side effects that may be uncomfortable and affect your appearance. These side effects, however, are manageable. Hair Loss...
View ArticleArsenic may be a very active anti-cancer agent for the treatment of patients...
Arsenic may be a very active anti-cancer agent for the treatment of patients with acute leukemia. Current standard treatment of acute promyelocytic leukemia utilizes all-trans-retinoic acid; however,...
View ArticleAll transretinoic acid (ATRA) combined with chemotherapy results in superior...
All transretinoic acid (ATRA) combined with chemotherapy results in superior outcomes for patients with acute promyelocytic leukemia. It has been known for several years that ATRA is an active drug...
View ArticleRemissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly...
Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Patients with Acute Promyelocytic Leukemia All-trans retinoic acid administered orally (oral ATRA) is a...
View ArticleNew Techniques Allowing Earlier Detection of Leukemia Recurrence and Prompt...
New Techniques Allowing Earlier Detection of Leukemia Recurrence and Prompt Treatment May Improve Outcomes for Patients with Acute Promyelocytic Leukemia Patients with acute promyelocytic leukemia...
View ArticlePatients Die Unexpectedly Following Treatment with Arsenic Trioxide
Patients Die Unexpectedly Following Treatment with Arsenic Trioxide Three sudden deaths occurred in a small clinical trial involving patients treated with arsenic trioxide for recurrent acute...
View ArticleArsenic may be a very active anti-cancer agent for the treatment of patients...
Arsenic may be a very active anti-cancer agent for the treatment of patients with acute leukemia. Current standard treatment of acute promyelocytic leukemia utilizes all-trans-retinoic acid; however,...
View ArticleArsenic: An Effective New Treatment for Acute Promyelocytic Leukemia
Arsenic: An Effective New Treatment for Acute Promyelocytic Leukemia Acute promyelocytic leukemia is a cancer of the blood. Initial treatment typically consists of all-trans retinoic acid (ATRA) and...
View ArticleFDA Approves Arsenic for Treatment of Promyelocytic Leukemia
FDA Approves Arsenic for Treatment of Promyelocytic Leukemia The Food and Drug Administration has recently approved a chemotherapy agent, arsenic, for patients with acute promyelocytic leukemia who...
View ArticleArsenic may be a very active anti-cancer agent for the treatment of patients...
Arsenic may be a very active anti-cancer agent for the treatment of patients with acute leukemia. Current standard treatment of acute promyelocytic leukemia utilizes all-trans-retinoic acid; however,...
View ArticleNew Techniques Allowing Earlier Detection of Leukemia Recurrence and Prompt...
New Techniques Allowing Earlier Detection of Leukemia Recurrence and Prompt Treatment May Improve Outcomes for Patients with Acute Promyelocytic Leukemia Patients with acute promyelocytic leukemia...
View Article
